Lipoprotein(a) level and MIF gene variant predict incident metabolic syndrome and mortality
Altan Onat, Günay Can, Neslihan Çoban, İbrahim Dönmez, Hakan Çakır, Evin Ademoğlu, Nihan Erginel-Ünaltuna, Hüsniye Yüksel
DOI: 10.1136/jim-2015-000003 Published 28 January 2016
Altan Onat
1Department of Cardiology, Istanbul University, Istanbul, Turkey
Günay Can
2Department of Public Health, Cerrahpaşa Medical Faculty, Istanbul University, Istanbul, Turkey
Neslihan Çoban
3Department of Genetics, Institute for Experimental Medical Research, Istanbul University, Istanbul, Turkey
İbrahim Dönmez
4Department of Cardiology, Izzet Baysal University, Abant, Istanbul, Turkey
Hakan Çakır
5Darıca Farabi State Hospital, Istanbul, Turkey
Evin Ademoğlu
6Department of Biochemistry, Medical Faculty, Istanbul University, Istanbul, Turkey
Nihan Erginel-Ünaltuna
3Department of Genetics, Institute for Experimental Medical Research, Istanbul University, Istanbul, Turkey
Hüsniye Yüksel
1Department of Cardiology, Istanbul University, Istanbul, Turkey

Submit a Response to This Article
No eLetters have been published for this article.
Lipoprotein(a) level and MIF gene variant predict incident metabolic syndrome and mortality
Altan Onat, Günay Can, Neslihan Çoban, İbrahim Dönmez, Hakan Çakır, Evin Ademoğlu, Nihan Erginel-Ünaltuna, Hüsniye Yüksel
Journal of Investigative Medicine Feb 2016, 64 (2) 392-399; DOI: 10.1136/jim-2015-000003

Lipoprotein(a) level and MIF gene variant predict incident metabolic syndrome and mortality
Altan Onat, Günay Can, Neslihan Çoban, İbrahim Dönmez, Hakan Çakır, Evin Ademoğlu, Nihan Erginel-Ünaltuna, Hüsniye Yüksel
Journal of Investigative Medicine Feb 2016, 64 (2) 392-399; DOI: 10.1136/jim-2015-000003
Lipoprotein(a) level and MIF gene variant predict incident metabolic syndrome and mortality
Altan Onat, Günay Can, Neslihan Çoban, İbrahim Dönmez, Hakan Çakır, Evin Ademoğlu, Nihan Erginel-Ünaltuna, Hüsniye Yüksel
Journal of Investigative Medicine Feb 2016, 64 (2) 392-399; DOI: 10.1136/jim-2015-000003